【参考資料4】抗微生物薬適正使用の手引き 第三版 本編 (131 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/newpage_45318.html |
出典情報 | 厚生科学審議会 感染症部会 薬剤耐性(AMR)に関する小委員会 抗微生物薬適正使用(AMS)等に関する作業部会(第6回 11/19)《厚生労働省》 |
ページ画像
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
第三版
61. Lee RA, et al. Appropriate Use of Short-Course Antibiotics in Common Infections: Best
Practice Advice from the American College of Physicians. Ann Intern Med. 2021
Jun;174(6):822-827.
62. Abbas M et al. Association between treatment duration and mortality or relapse in adult
patients with Staphylococcus aureus bacteraemia: a retrospective cohort study. Clin
Microbiol Infect, 2020 May;26(5):626-631.
63. Lafaurie M. et al. Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A
Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Clin
Infect Dis. 2023 Jun;76(12):2154-2162.
64. Bernard L. et al. Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection. N Engl J
Med. 2021 May;384(21):1991-2001.
65. Sehgal I. et al. Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to
prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled
trial in India, Lancet Infect Dis. 2022 Jul;22(7):1052-1061.
66. Corey GR. et al. Short-course therapy for bloodstream infections in immunocompetent
adults. Int J Antimicrob Agents. 2009;34(4):S47-51.
67. Vento S. et al. Lung infections after cancer chemotherapy. Lancet Oncol. 2008
Oct;9(10):982-992.
68. Rolston KVI. Infections in Cancer Patients with Solid Tumors: A Review. Infect Dis Ther. 2017
Mar;6(1):69-83.
69. Geerlings ES. Clinical Presentations and Epidemiology of Urinary Tract Infections. Microbiol
Spectr. 2016 Oct;4(5)
70. Lipsky AB. et al. Treatment of bacterial prostatitis, Clin Infect Dis. 2010 Jun;50(12):16411652.
71. Kalil CA. et al. Management of Adults With Hospital-acquired and Ventilator-associated
Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America
and the American Thoracic Society. Clin Infect Dis. 2016 Sep;63(5):e61-111.
72. Bouglé A. et al. Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas
aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label
trial. Intensive Care Med. 2022 Jul;48(7):841-849.
73. Pappas PG. et al. Clinical Practice Guideline for the Management of Candidiasis: 2016
Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Feb;62(4):e1-50.
74. Baddour LM. et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and
Management of Complications: A Scientific Statement for Healthcare Professionals From the
American Heart Association. Circulation. 2015 Oct;132(15):1435-1486.
75. Klompas M. Set a short course but follow the patient’s course for ventilator-associated
pneumonia. Chest. 2013 Dec;144(6):1745-1747.
76. Cosgrove ES et al. Management of methicillin-resistant Staphylococcus aureus bacteremia,
Clin Infect Dis. 2008 Jun;46(5):S386-393.
77. Liu C. et al. Clinical practice guidelines by the infectious diseases society of america for the
treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
Clin Infect Dis. 2011 Feb;52(3):e18-55.
131